Ber Gerard
Director at Y-mAbs Therapeutics, Inc.; Director at LNTH
- Sold, on record
- $1.6M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Aug 12, 2024
- Form 144 notices
- 3
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Y-mAbs Therapeutics, Inc.Director
- LNTHLantheus Holdings, Inc.Director
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- LNTH16,777 shares
- Y-mAbs Therapeutics, Inc.722 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LNTHPlan not statedMay 10, 2022 2022
Sold 1,277 shares at $58.19 ($74k)
Ber Gerard, Director
Sold 3.8% of holdings ($2M position)32,703 shares leftFirst sale on recordFiling
- 2 Form 144 notice Y-mAbs Therapeutics, Inc.NoticeJun 10, 2024 +762 days
Filed to sell 722 shares ($9k)
Ber Gerard, Director
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale Y-mAbs Therapeutics, Inc.UnusualJun 10, 2024 same day
Sold 722 shares at $12.00 ($9k)
Ber Gerard, Director
No 10b5-1 planSold 31% of holdings ($28k position)1,608 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 144 notice LNTHNoticeAug 12, 2024 +63 days
Filed to sell 15,500 shares ($1.5M)
Ber Gerard, Director
10b5-1 planFirst sale on recordFiling
- 5 Form 4 sale LNTHRoutineAug 12, 2024 same day
Sold 15,500 shares at $96.48 ($1.5M)
Ber Gerard, Director
10b5-1 planSold 42.2% of holdings ($3.5M position)21,221 shares leftFirst sale on recordFollows a Form 144Filing
- 6 Form 144 notice Y-mAbs Therapeutics, Inc.NoticeSep 3, 2024 +22 days
Filed to sell 13,950 shares ($193k)
Ber Gerard, Director
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Sep 3, 2024 | Y-mAbs Therapeutics, Inc. | Director | Form 144 notice | 13,950 | $193k | Notice | SEC | |
| Aug 12, 2024 | Aug 14, 2024 | LNTH | Director | Form 4 sale | 15,500 | $1.5M | 42.2% | Routine | SEC |
| Aug 12, 2024 | Aug 12, 2024 | LNTH | Director | Form 144 notice | 15,500 | $1.5M | Notice | SEC | |
| Jun 10, 2024 | Jun 11, 2024 | Y-mAbs Therapeutics, Inc. | Director | Form 4 sale | 722 | $9k | 31.0% | Unusual | SEC |
| Jun 10, 2024 | Jun 10, 2024 | Y-mAbs Therapeutics, Inc. | Director | Form 144 notice | 722 | $9k | Notice | SEC | |
| May 10, 2022 | May 12, 2022 | LNTH | Director | Form 4 sale | 1,277 | $74k | 3.8% | Plan not stated | SEC |